Alpha Dna Investment Management LLC Kura Oncology, Inc. Transaction History
Alpha Dna Investment Management LLC
- $250 Million
- Q2 2024
Shares
3 transactions
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$138 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$136 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$113 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$106 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$88.6 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.31B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...